Serum phosphorus levels in premature infants receiving a donor human milk derived fortifier

Katherine E Chetta1, Amy B Hair2, Keli M Hawthorne3

  • 1USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Section of Neonatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA. kewiley@bcm.edu.

Nutrients
|April 28, 2015
PubMed

Insights

Premature infants receiving human milk fortified with donor human milk-derived fortifier (HMDF) may experience mild, temporary high serum phosphorus levels. This risk decreases with infant age and is not linked to birth weight or gender.

Area of Science:

  • Neonatal Nutrition
  • Pediatric Endocrinology
  • Human Milk Fortification

Background:

  • Anecdotal reports suggest elevated serum phosphorus (P) in premature infants fed donor human milk-derived fortifier (HMDF).
  • Prospective studies investigating serum P levels in this specific population are lacking.

Purpose of the Study:

  • To prospectively evaluate serum phosphorus levels in extremely premature infants fed an exclusive human milk-based diet with HMDF.
  • To identify factors associated with serum P elevations in this cohort.

Main Methods:

  • A single-center prospective observational cohort study.
  • Included 93 extremely premature infants (≤ 1250g birth weight).
  • Monitored serum P levels and analyzed correlations with infant characteristics and HMDF energy density.

Main Results:

  • 18.3% of infants had at least one high serum P level (mean 9.2 ± 1.1 mg/dL) around 19 days of life.
  • Highest serum P was inversely correlated with infant age (p < 0.001) and positively correlated with HMDF energy density (p = 0.035).
  • Serum P showed no significant relationship with gender, birth weight, gestational age, or time to full feeds.

Conclusions:

  • Hyperphosphatemia incidence in premature infants receiving HMDF was mild and transient.
  • Risk of elevated serum P decreased with infant age.
  • Serum P levels were not significantly related to infant demographics or feeding milestones.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
4.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
647
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871